Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03830866
Title Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA) (CALLA)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications

cervical adenocarcinoma

cervical squamous cell carcinoma

Therapies

Durvalumab

Cisplatin + Durvalumab

Carboplatin + Durvalumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.